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1338Objectives: Previous studies demonstrated beneficial short-term effects of surgical ventricular restoration on me-
chanical dyssynchrony and left ventricular function and improved midterm and long-term clinical parameters.
However, long-term effects on systolic and diastolic left ventricular function are still largely unknown.
Methods: We studied 9 patients with ischemic dilated cardiomyopathy who underwent surgical ventricular
restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting. Invasive hemo-
dynamic measurements by conductance catheter (pressure–volume loops) were obtained before and 6 months
after surgery. In addition, New York Heart Association classification, quality-of-life score, and 6-minute hall-
walk test were assessed.
Results: At 6 months’ follow-up, all patients were alive and clinically in improved condition: New York Heart
Association class from 3.3  0.5 to 1.4  0.7, quality-of-life score from 46  22 to 15  15, and 6-minute hall-
walk test from 302 123 to 444 78m (all P<.01). Hemodynamic data showed improved cardiac output (4.8
1.4 to 5.6  1.1 L/min), stroke work (6.5  1.9 to 7.1  1.4 mm Hg $ L; P ¼ .05), and left ventricular ejection
fraction (36% 10% to 46% 10%; P<.001). Left ventricular surgical remodeling was sustained at 6 months:
end-diastolic volume decreased from 246 70 to 180 48 mL and end-systolic volume from 173 77 to 103
40 mL (both P<.001). Left ventricular dyssynchrony decreased from 29% 6% to 26% 3% (P<.001) and
ineffective internal flow fraction decreased from 58%  30% to 42%  18% (P< .005). Early relaxation
(Tau, minimal rate of pressure change) was unchanged, but diastolic stiffness constant increased from 0.012 
0.003 to 0.023  0.007 mL1 (P< .001).
Conclusions: Surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary ar-
tery bypass grafting leads to sustained left ventricular volume reduction at 6 months’ follow-up. We observed
improved systolic function and unchanged early diastolic function but impaired passive diastolic properties. Clin-
ical improvement, supported by decreased NewYork Heart Association class, improved quality-of-life score, and
improved 6-minute hall-walk test may be related to improved systolic function, reduced mechanical dyssyn-
chrony, and reduced wall stress. (J Thorac Cardiovasc Surg 2010;140:1338-44)Chronic heart failure is a leading cause of morbidity and mor-
tality.Most affected patients have an ischemic etiology, and in
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The Journal of Thoracic and Cardiovascular Suris a frequent complication. Abnormal LV geometry and dys-
coordinate wall motion may cause a highly inefficient pump
function. Ultimately, adverse effects on the remote myocar-
dium, which is exposed to increased workload at enhanced
wall stress despite compensatoryhypertrophy,may lead to car-
diac failure. Patients with LV aneurysm often remain symp-
tomatic despite optimal medical treatment, and surgery may
be indicated. Surgical ventricular restoration (SVR) by means
of endoventricular circular patch plasty is increasingly per-
formed. With this procedure, akinetic or dyskinetic sections
of the anterior wall and septum are excluded to normalize cav-
ity volume and to reshape an elliptical LV, using a Dacron
patch to establishwall continuity and ensure adequate residual
volume. Studies have shown that SVR is effective and rela-
tively safe with a favorable 5-year outcome,1,2 although the
additional effect of SVR to coronary artery bypass graftinggery c December 2010
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CO ¼ cardiac output
dP/dtMAX ¼ maximal rate of pressure change
dP/dtMIN ¼ minimal rate of pressure change
EA ¼ effective arterial elastance
EDP ¼ end-diastolic pressure
EDPVR ¼ end-diastolic pressure–volume relation
EDV ¼ end-diastolic volume
EED ¼ diastolic stiffness
EES ¼ end-systolic elastance
ESP ¼ end-systolic pressure
ESPVR ¼ end-systolic pressure–volume relation
ESV ¼ end-systolic volume
ESV125 ¼ end-systolic volume intercept
at 125 mm Hg
HR ¼ heart rate
KED ¼ stiffness constant
LV ¼ left ventricular (ventricle)
MR ¼ mitral regurgitation
NYHA ¼ New York Heart Association
PRSW ¼ preload recruitable stroke work
SV ¼ stroke volume
SVR ¼ surgical ventricular restoration
SW ¼ stroke work
Tau ¼ time constant of relaxation
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D(CABG) remains debated.3,4 SVR is also frequently combined
with mitral valve repair, and the impact of that procedure in
patients with heart failure has been the subject of several
recent studies.5 Recent hemodynamic studies demonstrated
that SVR may acutely reduce LV mechanical dyssynchrony
and wall stress and improve LV systolic function.6 However,
as predicted by theoretical studies, SVR may be associated
with diastolic dysfunction limiting the overall beneficial
effects on cardiac pump function. Adverse effects on diastolic
function were previously demonstrated in the acute phase,6
but accurate long-term human data of the potentially differen-
tial effects of SVR on systolic and diastolic function are lack-
ing. Therefore, we studied the long-term hemodynamic effects
in patients with heart failure and ischemic dilated cardiomyop-
athy treated with SVR. Additional surgery included restrictive
mitral annuloplasty and/or CABG. Global, systolic, and
diastolic LV function were assessed invasively using conduc-
tance catheter–derived pressure–volume loops before surgery
and at 6 months’ follow-up.METHODS
Patients
The study group consisted of 9 patients with ischemic dilated cardiomy-
opathy, New York Heart Association (NYHA) class III/IV, and LV ejectionThe Journal of Thoracic and Carfraction less than 35% who underwent SVR. In 8 patients with moderate-
to-severe mitral regurgitation (MR grade  2) additional restrictive mitral
annuloplasty was performed. All patients underwent additional CABG
(CABG, n ¼ 8) or had recent percutaneous coronary intervention (n ¼ 1).
The protocol was approved by our institutional ethics committee and all pa-
tients gave informed consent. Patient characteristics, medication, and surgi-
cal data are summarized in Table 1.
Study Protocol
Baseline hemodynamic data were obtained during diagnostic catheteri-
zation, 25  18 days before surgery, including thermodilution cardiac out-
put, ventriculography, and coronary angiography. In addition, a 7F
conductance catheter (CD-Leycom, Zoetermeer, The Netherlands) was
placed in the LV via the femoral artery and a temporary pacing lead in
the right atrium to obtain pressure–volume loops at fixed incremental (80,
100, 120 beats/min) heart rates (HRs). LV volume was calibrated by ther-
modilution and hypertonic saline dilution. Data were acquired at least 1
minute after changing to a higher HR and periods of 20 seconds were se-
lected for offline analysis. All measurements were repeated after SVR dur-
ing recatheterization at 6.5  0.8 months’ follow-up.
Echocardiography
Additional transesophageal echocardiography was performed within
5 days before surgery on patients with moderate-to-severe MR (grade
2) seen on transthoracic echocardiography. Transesophageal echocardiog-
raphy was done without general anesthesia to avoid underestimation of MR.
Severity was graded semiquantitatively from color Doppler in conventional
parasternal long-axis and apical 4-chamber images. Immediately after sur-
gery, transesophageal echocardiography was repeated to exclude residual
MR. At 6 months’ follow-up, repeat transthoracic echocardiography as-
sessed possible recurrent MR. All transthoracic echocardiography measure-
ments were analyzed in random order by two independent observers without
knowledge of the clinical status of the patient.
Surgical Procedures
Surgical procedures were performed using normothermic cardiopulmo-
nary bypass with intermittent antegrade warm blood cardioplegia. After me-
dian sternotomy, patients underwent conventional CABG, with internal
thoracic arteries when possible. Next, SVR was performed by an endoven-
tricular circular patch plasty as previously described by Dor.7 In brief, the
LV was opened through the infarcted area. An endocardial encircling suture
(Fontan stitch) was placed at the transitional zone between scarred and nor-
mal tissue. A balloon containing 55 mL of saline per square meter of body
surface area was introduced into the LV. The Fontan stitch was tightened to
approximate the ventricular wall to the balloon. An oval Dacron patch was
tailored and used to close the residual orifice. The excluded scar tissue was
closed over the patch to ensure hemostasis. Care was taken to eliminate all
septal scar and to delineate a new LV apex with the goal to restore the nor-
mal elliptical shape. After completion of the LV restoration, a stringent re-
strictive mitral annuloplasty (2 sizes smaller than the measured size) was
performed by the atrial transseptal approach using a Carpentier–Edwards
Physio ring (Edwards Lifesciences, Irvine, Calif).
Data Analysis
Hemodynamic indexes were calculated with custom-made software as
the mean of all beats during a steady state period of 20 seconds at each
paced HR level. LV function was quantified by cardiac output (CO), LV
ejection fraction, stroke volume (SV), end-diastolic and end-systolic volume
(EDV, ESV) and pressure (EDP, ESP), andmaximal andminimal rate of LV
pressure change (dP/dtMAX,dP/dtMIN). Stroke work (SW) was calculated
as the pressure–volume loop area. Afterload (effective arterial elastance,
EA) was calculated as ESP/SV and mechanical efficiency (ME) as the ratio
of SW and pressure–volume area (PVA): ME ¼ SW/PVA.8 To determinediovascular Surgery c Volume 140, Number 6 1339
TABLE 1. Patient characteristics
Baseline
Six months’
follow-up
Patients (n) 9
Male (female) (n) 7 (2)
Age (y) 62  6
Mean No. of stenosed coronary arteries 2.0  1.0
QRS duration (ms) 109  19 112  15
Clinical characteristics
NYHA class 3.3  0.5 1.4  0.7*
6-min hall-walk test (m) 302  123 444  78*
Quality-of-life score 46  22 15  15*
Medication
Diuretics 6 (67%) 7 (78%)
Beta-blockers 7 (78%) 6 (67%)
ACE inhibitors/AT antagonists 8 (89%) 6 (67%)
Cholesterol inhibitors 8 (89%) 8 (89%)
Vasodilators 2 (22%) 1 (11%)
Aspirin/anticoagulants 8 (89%) 6 (67%)
Surgical data
Surgical intervention
SVRþRMAþCABG 7 (78%)
SVRþRMA 1 (11%)
SVRþCABG 1 (11%)
Ring size (RMA) 25  1
Mitral regurgitation grade 2.0  1.2 0.3  0.5*
No. of distal anastomoses 3  1
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and volume, P(t) and V(t), and LV mass as described by Arts and associ-
ates9:WS(t)¼ P(t) $ (1þ3 $V(t)/LVmass). LVmass was based on diastolic
posterior wall thickness derived from M-mode echocardiography. The end-
systolic pressure–volume relation (ESPVR) was determined by single-beat
analysis and quantified by its slope EES (end-systolic elastance) and volume
intercept at 125 mm Hg (ESV125) as detailed elsewhere.
10 The preload
recruitable stroke work (PRSW) relation was determined as described by
Lee and colleagues11 and characterized by slopeMW and volume axes inter-
cept VW. The time constant of relaxation (Tau) was determined by phase-
plot analysis. The end-diastolic pressure–volume relation (EDPVR) was
derived from the filling phase trajectory of the pressure–volume loop includ-
ing all data points between the moments of minimal pressure and maximal
volume. LV diastolic stiffness (EED) was determined as the linear slope of
the EDPVR and the stiffness constant (KED) from an exponential fit
(EDP¼A $ exp(KED $ EDV). EDPVR position was defined by the intercept
at 18 mm Hg (EDV18). LV mechanical dyssynchrony was determined from
the segmental conductance signals.12 In addition, we calculated internal
flow fraction to quantify the ineffective shifting of blood volume within
the LV owing to nonuniform contraction and relaxation.12
Statistical Analysis
We used a linear mixed-effects model with patients included as random
effects and conditions (baseline, 6 months’ follow-up), pacing (80, 100 and
120 beats/min), and their interaction as fixed effects. This model accounts
for correlation between repeated measurements. Data are presented as
mean SD. All analyses were performed using the statistical software pro-
gram SPSS 16.0 (SPSS, Inc, Chicago, Ill). The authors had full access to the
data and take responsibility for its integrity. All authors have read and agree
to the manuscript as written.
Cardiopulmonary bypass (min) 222  46
Aorta crossclamping (min) 153  28
Intensive care unit stay (d) 4  2
Hospital stay (d) 16  5
Intra-aortic balloon pump 2 (22%)
Inotropic supporty>24 h 6 (66%)
NYHA,NewYorkHeartAssociation;ACE, angiotensin-convertingenzyme;AT, angioten-
sin; SVR, surgical ventricular restoration; RMA, restrictive mitral annuloplasty; CABG,
coronary artery bypass grafting.Data are presentedasnumber of patients involved andper-
cent of the total group or as mean SD. *P< .01. yDobutamine>2 mg $ kg1 $ min1.RESULTS
Patient clinical characteristics and medication are reported
inTable 1.Note that in thepresent studywe includeda selected
group of patients with complete hemodynamic follow-up by
pressure–volume loops. In the associated 2-year interval,
a total of 39 patients with NYHA class III/IV underwent
SVR in our center. The operativemortality in this entire group
was 10.3%, and 6 months’ survival was 87%.Surgical and Clinical Data
Surgery was associated with an aortic crossclamping time
of 153  28 minutes and a total cardiopulmonary bypass du-
ration of 222  46 minutes. In all cases, intraoperative trans-
esophageal echocardiography excluded residual MR. Two
patients needed an intra-aortic balloon pump to wean from
CPB and 6 patients needed inotropic support (dobutamine
>2 mg $ kg1 $min1) for more than 24 hours postoperatively.
Hospital stay was 16 15 days with an intensive care stay of
4  2 days. All patients were discharged from the hospital in
good clinical condition. At 6 months’ follow-up, QRS dura-
tion was unchanged and the clinical status of the patients
showed significant improvements (Table 1).Hemodynamic Data
Hemodynamic data are summarized in Table 2. The statis-
tical model tested differences between conditions (baseline,
6 months’ follow-up), effect of HR (pacing), and the interac-1340 The Journal of Thoracic and Cardiovascular Surtion between conditions and pacing. The latter would indi-
cate whether effects of pacing were different between both
conditions; however, none of the variables showed signifi-
cant interaction. At follow-up, global LV function was
improved as evidenced by significantly increased SW
(P ¼ .05), a tendency for increased CO and SV (P ¼ .09,
P ¼ .06), and reduced peak wall stress (P< .001). ESV
and EDV were significantly reduced (both P< .001) with
respectively40% and27% (at 80 beats/min), indicating
substantial persistent reverse LV remodeling. The signifi-
cant increase in SW combined with unchanged pressure–
volume area resulted in an improved mechanical efficiency,
which however did not reach statistical significance
(P ¼ .113). Systolic function was improved as evidenced
by a significantly increased slope and leftward shift of the
PRSW relation (P ¼ .004, P< .001). Furthermore, we ob-
served an increased LV ejection fraction and reduced
ESV125 (both P< .001). EES and the arterial/ventriculargery c December 2010
TABLE 2. Hemodynamics by pressure–volume loops at baseline and 6 months’ follow-up after SVR
Baseline (beats/min) Six months’ follow-up (beats/min) P values
80 100 120 80 100 120 Condition Pacing Interaction
General
HR (beats/min) 79.5  2.9 99.3  2.8 121.9  2.6 82.6  2.0 101.7  1.4 122.0  2.1 .003 <.001 .145
CO (L/min) 4.8  1.4 4.7  2.3 5.8  2.5 5.6  1.1 5.7  1.7 5.3  2.3 .090 .528 .229
SV (mL) 60  17 47  23 48  21 68  13 56  16 43  19 .060 <.001 .271
SW (mm Hg $ L) 6.5  1.9 4.9  1.9 4.9  2.1 7.1  1.4 6.0  1.1 4.4  1.3 .050 <.001 .296
EA (mm Hg/mL) 2.5  1.1 3.9  2.3 3.2  2.0 2.0  0.7 2.4  1.0 3.3  1.6 .013 .011 .227
EA/EES 2.24  1.17 2.19  1.10 2.60  1.36 1.93  0.61 2.16  0.66 2.64  1.18 .163 .045 .793
ME 0.49  0.12 0.48  0.11 0.45  0.15 0.53  0.11 0.51  0.10 0.47  0.13 .113 .078 .964
PVA (mm Hg $ L) 14.1  6.6 10.5  4.1 11.0  3.3 14.0  4.1 12.1  3.1 9.4  1.7 .763 .003 .511
PWS (mm Hg) 431  177 434  188 465  240 310  125 307  118 285  115 <.001 .988 .836
Systole
ESV (mL) 173  77 180  87 184  93 103  40 105  44 100  51 <.001 .958 .940
ESP (mm Hg) 133  32 129  29 122  25 126  27 123  25 114  22 .088 .140 .958
EF (%) 36  10 33  12 32  11 46  10 42  12 40  13 <.001 .121 .865
dP/dtMAX (mm Hg/s) 1291  274 1368  261 1424  324 1291  225 1384  209 1384  224 .919 .138 .932
EES (mm Hg/mL) 1.2  0.6 1.6  0.7 1.5  0.7 1.1  0.5 1.2  0.4 1.3  0.6 .087 .378 .792
ESV125 (mL) 165  96 178  91 187  101 103  51 111  57 114  65 <.001 .820 .968
MW (mm Hg) 38  15 29  15 31  16 48  7 42  8 32  11 .004 .003 .415
VW (mL) 79  85 76  91 91  86 29  51 23  52 9  54 <.001 .772 .802
Diastole
EDV (mL) 246  70 241  78 243  86 180  48 171  49 151  52 <.001 .527 .823
EDP (mm Hg) 19.8  8.6 19.8  10.0 19.7  9.3 19.0  7.6 15.6  8.1 11.2  6.1 .021 .118 .262
dP/dtMIN (mm Hg/s) 1166  238 1180  213 1180  232 1187  287 1211  250 1180  229 .685 .857 .901
Tau (ms) 80  14 74  14 67  16 82  17 76  14 70  12 .351 .003 .895
EED (mm Hg/mL) 0.15  0.08 0.14  0.08 0.14  0.07 0.24  0.11 0.24  0.16 0.23  0.18 <.001 .821 .960
KED (mL
1) 0.012  0.003 0.010  0.006 0.012  0.012 0.023  0.007 0.026  0.017 0.035  0.032 <.001 .434 .530
EDV18 (mL) 261  93 248  102 266  115 198  40 190  56 194  62 <.001 .860 .994
Dyssynchrony
DYS (%) 29.3  5.5 29.4  6.1 29.0  6.3 26.3  3.4 25.9  3.4 25.4  2.7 <.001 .800 .912
IFF (%) 58  30 62  35 60  34 42  18 41  15 39  15 .004 .856 .959
SVR, Surgical ventricular restoration; HR, heart rate; CO, cardiac output; SV, stroke volume; SW, stroke work; EA, arterial elastance; EES, end-systolic elastance (slope of ESPVR,
end-systolic pressure-volume relation);ME, mechanical efficiency; PVA, pressure-volume area; PWS, peak wall stress; ESV, end-systolic volume; ESP, end-systolic pressure; EF,
ejection fraction; dP/dtMAX,maximal rate of pressure change; ESV125, ESPVR intercept at 125 mmHg;MW, slope of PRSW (preload recruitable stroke work relation); VW, intercept
of PRSW; EDV, end-diastolic volume; EDP, end-diastolic pressure;dP/dtMIN, minimum rate of pressure change; Tau, pressure relaxation time constant; EED, diastolic stiffness;
KED, diastolic stiffness constant; EDV18, intercept of EDPVR (end-diastolic pressure-volume relation) at 18mmHg; DYS, mechanical dyssynchrony; IFF, internal flow fraction.
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though afterload (EA) decreased significantly (P ¼ .013).
Passive diastolic function showed impairment indicated by
increased EED and KED (both P<.001). However, early, ac-
tive relaxation indexed by Tau anddP/dtMIN was unaltered
after SVR. EDV, calculated from the EDPVR at 18 mm Hg,
was significantly reduced, reflecting lower operating vol-
umes consistent with a leftward shift of the pressure–volume
loop. Mechanical dyssynchrony and internal flow fraction
were significantly (P < .001, P ¼ .004) reduced with
10% and 28%, respectively, indicating substantially
reduced dyssynchrony.DISCUSSION
Previous research has shown that SVR is an effective ther-
apy for patients with end-stage ischemic heart failure
according to acceptable survivals, improved clinical perfor-The Journal of Thoracic and Carmance, and sustained LV reverse remodeling diagnosed by
echocardiography at midterm and long-term follow-up.13,14
Several previous studies examined the acute hemodynamic
status after SVR showing the expected volume reductions,
a decrease of mechanical dyssynchrony, improved systolic
function, and impaired diastolic function, which effects
however could be partly transient.6 The present study there-
fore was designed to analyze the chronic effects of SVR
with additional restrictive mitral annuloplasty and/or CABG
on several aspects of LV function, including chronotropic re-
sponses, at 6months’ follow-up.To our knowledge, long-term
follow-up data, including invasive pressure–volume indices,
have not been published previously for this patient group.Global LV Function
Our results demonstrate sustained reverse LV remodeling
with reduced ESV (40%) and EDV (27%) at 6 months’diovascular Surgery c Volume 140, Number 6 1341
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volume reductions.6 In line with other studies, CO and SV
showed a tendency to increase but did not reach statistical
significance, whereas SW increased significantly after
SVR.14,15 Afterload (EA) decreased significantly, which
was also observed by Fantini and coworkers,16 whereas
mechanical efficiency and pressure–volume area did not
change significantly. Consequently, calculated wall stress,
an important determinant of myocardial oxygen consump-
tion, decreased substantially (28%), which may partly
explain improved clinical performance. Our results regard-
ing long-term relative volume reduction are in line with
most previous studies at midterm follow-up (4–12
months).1,17-19 Likewise, the mean ESV index obtained at
6 months after SVR (53  21 mL/m2) is in the same range
as follow-up values reported in larger series by, for example,
the RESTORE group1 (57  34mL/m2), Dor and co-
workers18 (51 18 mL/m2), and Di Donato and associates17
(average of 3 groups: 44  20 mL/m2).
Systolic LV Function
Our data confirm previous findings regarding signifi-
cantly improved LV ejection fraction after SVR. However,
this may be partly due to reduced afterload and, more in gen-
eral, the relevance of increased LV ejection fraction after
SVR has been questioned. Therefore, additional systolic in-
dices derived from load-independent pressure–volume rela-
tions ESPVR and PRSWwere investigated. ESPVR showed
a leftward shift evidenced by reduced ESV125, indicating im-
proved systolic function, but the slope EES was not signifi-
cantly altered. EES is often used to index systolic function;
however, in case of regional dysfunction, the ESPVR may
primarily show parallel shifts rather than a decreased slope
presumably because at systolic pressure levels the aneurysm
is very stiff.20 The PRSW relation showed a leftward shift
(reduced intercept of PRSW) and increased slope of
PRSW, both indicating improved systolic function.
Although PRSW is predominantly a measure of systolic
function, alterations in diastolic function also affect this re-
lation. However, the negative effects on diastolic function
in this case would tend to decrease the PRSW slope and
thus partly mask even more positive systolic effects. The im-
proved global systolic function presumably was related to
improved functioning of the remote myocardium by reduced
wall stress and reduced mechanical dyssynchrony.
Diastolic Function
Early active relaxation (dP/dtMIN, Tau) was unchanged
after SVR, but passive diastolic stiffness was significantly
increased. The fact thatdP/dtMIN and Tau did not change, de-
spite the substantial volume reduction, could result from neg-
ative effects due to a distortion of the normal myocardial fiber
orientation.21 Apparently, increased diastolic stiffness ob-
served acutely after SVR6 which, however, did not reach sig-1342 The Journal of Thoracic and Cardiovascular Surnificance (pre-SVR: KED 0.021  0.009 mL1 , post-SVR:
KED 0.037 0.02 mL1; P¼ .147) is still present at 6 months
and thus not merely a transient effect of cardioplegic arrest.
The significantly increased KED in the present study cannot
be directly compared with the results of the previous short-
term study performed in the operating room,6 because other
effects related to the perioperative conditions may also play
a role.9 To put these values into perspective, Kasner and asso-
ciates22 recently reported KED to be approximately 0.010
mL1 in normals and 0.029 mL1 in patients with heart failure
and normal ejection fraction, whereas in patients with hyper-
trophic obstructive cardiomyopathy a value of 0.025 mL1
was found by Steendijk and coworkers.23 Thus, the baseline
values for KED in the present study of 0.012 0.003mL1 ap-
pear to be in the normal range, whereas 0.023  0.007 mL1
observed 6 months after surgery is close to values observed in
patient groups with diastolic dysfunction. A study by Zhang
and colleagues24 in sheep also reported a tendency for in-
creased diastolic stiffness up to 6 weeks after SVR. Further-
more, a few other studies have reported filling abnormalities
after SVR and suggested that a marked reduction of LV
size may result in a restrictive LV filling pattern.25,26 In our
data set, we also found a correlation between the reduction
in EDV and the increase in diastolic stiffness constant
(%DKED ¼ 41.9 3.0 $ %DEDV, r2 ¼ 0.55, P< .01).
This finding suggests that a restriction in the amount of LV
volume reduction could be relevant to avoid diastolic
dysfunction. However, the number of patients is too small
to draw firm conclusions and further studies are needed to
address this issue.
Dyssynchrony
Mechanical dyssynchrony is increasingly recognized as
an important factor explaining LV dysfunction. Earlier stud-
ies6 demonstrated an immediate improvement in dyssyn-
chrony after SVR and the present data indicate persistent
improvement at 6 months. The reduced dyssynchrony pre-
sumably underlies the improved systolic function, whereas
the reduced intraventricular shifting of blood volume
indexed by internal flow fraction will contribute to a more
efficient pump function.
HR Effect
We performed measurements during pacing to exclude
bias by altered HR and to investigate HR dependencies be-
fore and after SVR. Statistical analysis showed that CO
tended (P ¼ .09) to be higher after SVR (þ18% at 80
beats/min) but the effect of pacing on CO was unaltered, in-
dicating a remaining lack of chronotropic reserve. As shown
in Figure 1, SV (width of pressure–volume loop) gradually
decreased at higher HR, limiting the CO increase. Interest-
ingly, it appeared that the reduction in SV was mainly due
to an increase in ESV at baseline, but due to a decrease in
EDV at 6 months’ follow-up, suggesting that the resolvedgery c December 2010
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FIGURE 1. Schematic pressure–volume loops (based on mean end-diastolic and end-systolic pressures and volumes) at baseline (left panel) and 6 months
after surgical ventricular restoration (SVR) (right panel). Loops are shown during pacing at 80, 100, and 120 beats/min (p80, p100, p120). Baseline p80 data
are repeated in the right panel (dotted lines) to illustrate the substantial volume reduction induced by SVR. LV, Left ventricular.
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FIGURE 2. Typical examples of end-diastolic pressure–volume relation-
ships (EDPVR) at baseline and 6 months after surgical ventricular restora-
tion (SVR) illustrating increased diastolic stiffness constant (KED) and
reduced LV volume. EDPVR intercepts at 18mmHg (EDV18) are indicated.
EDP, End-diastolic pressure; EDV, end-diastolic volume.
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However, these pacing effects did not reach statistical signif-
icance and thus remain speculative. Interestingly, the re-
sponse to pacing after SVR appears to be similar to that
observed in patients with heart failure and preserved ejection
fraction.27 It should be noted that increased HR by pacing
only partly mimics the effects of exercise. Given the drop
in EDP during pacing after SVR, sympathetic stimulation
and volume recruitment during true exercise may lead to
a more positive effect on CO bymaintaining or even increas-
ing normal filling pressures.27
Additional Surgery
In this study SVR was the primary indication for surgery,
but additional CABG and/or restrictive mitral annuloplasty
was performed in all patients. Therefore, the reported effects
cannot be attributed to SVRalone. Revascularization has been
shown to have beneficial effects in patients with ischemic di-
lated cardiomyopathy.28 Moreover, a recent randomized trial
concluded that adding SVR to CABG in patients eligible for
both procedures was not associated with greater clinical
benefits than CABG alone, despite the fact that a larger reduc-
tion in ESV indexwas obtained (19% vs 6%).3 However, this
trial is currently strongly debated, in particular because the
SVR-related volume reductions were much smaller than in
other SVR trials (typically 40%).29 Likewise, beneficial
clinical effects and significant long-term volume reductions
have been reported for restrictive mitral annuloplasty with
or without CABG.30,31 Pressure–volume loop studies in
patients with restrictive mitral annuloplasty alone are in
progress, but comparison with the present study will remain
difficult because studies are not randomized and baseline
characteristics of patients groups are different.
Study Limitations
In addition to the potentially confounding effects of addi-
tional surgery, the study is limited by a small sample size.The Journal of Thoracic and CarHowever, because we used each patient as his or her own
control, statistical power was optimized. Moreover, we
used invasive pressure–volume measurements, which are
generally regarded as highly accurate and the gold standard
for LV function assessments.CONCLUSIONS
Our findings provide insight into the long-term effects of
SVR on systolic and diastolic LV function and reveal that
the clinical improvements presumably are due to improved
systolic function and reduced dyssynchrony and wall stress,
leading to more efficient global pump function. However,
the surgical intervention may be associated with an adverse
effect on diastolic function limiting its full potentialdiovascular Surgery c Volume 140, Number 6 1343
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D(Figure 2). Further research is needed to investigate this is-
sue and whether patients who are prone to the development
of diastolic dysfunction should be excluded or whether mod-
ifications in the procedure such as an adaptation of the target
cavity volume should be considered. However, considering
the positive net effect of the surgical procedure on improved
clinical outcome, it is clear that the effect of SVR on systolic
function, dyssynchrony, and wall stress is more prominent
than the possible adverse effect on diastolic function.References
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